The Cell Brief

The Cell BriefCategory

Peptide News

Peptide news, explained simply: one big peptide story each week, from FDA decisions to new trials, with what it means and what comes next.

1 brief

The Cell BriefPeptide News

Report: U.S. Weighs Letting Some Peptides Be Sold for NowThe Washington Post reports a draft plan to let some unapproved peptides be sold for a while. Here is what we know, and what is still unknown.Oct 11, 2026